Cephalexin how supplied
Cephalexin |
---|
CEPHALEXIN®,KEFLEX® FDA Package Insert |
Description |
Clinical Pharmacology |
Microbiology |
Indications and Usage |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Overdosage |
Dosage and Administration |
How Supplied |
Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Cephalexin capsules USP—
250 mg: Swedish orange body and gray cap imprinted “TEVA” on the cap and “3145” on the body, in bottles of 100, 500, and unit-dose boxes of 100 (10 x 10).
500 mg: Swedish orange body and Swedish orange cap imprinted “TEVA” on the cap and “3147” on the body, in bottles of 100, 500, and unit-dose boxes of 100 (10 x 10).
Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].
Cephalexin for oral suspension* USP
(a cherry mixed fruit flavored formula)—
125 mg/5 mL: bottles of 100 mL and 200 mL.
250 mg/5 mL: bottles of 100 mL and 200 mL.
Directions for mixing are included on the label.
Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].
Shake well before using. Keep tightly closed.
- After mixing, store in refrigerator. May be kept for 14 days without significant loss of potency.
Cephalexin tablets USP—
250 mg: bottles of 100. Tablet identification number and color: white, capsule-shaped tablet, debossed “2238” on one side with a score between the “2” and the “3” and “TEVA” on the reverse side.
500 mg: bottles of 100. Tablet identification number and color: white, capsule-shaped tablet, debossed “2240” on one side with a score between the “2” and the “4” and “TEVA” on the reverse side.
Store dry powder at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].
References
http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050405s097lbl.pdf